These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 25356783)

  • 41. Correlation of screening and confirmatory results in tiered immunogenicity testing by solution-phase bridging assays.
    Kubiak RJ; Zhang L; Zhang J; Zhu Y; Lee N; Weichold FF; Yang H; Abraham V; Akufongwe PF; Hewitt L; Robinson S; Liu W; Liu X; Patnaik MM; Spitz S; Wu Y; Roskos LK
    J Pharm Biomed Anal; 2013 Feb; 74():235-45. PubMed ID: 23245256
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Bootstrap estimation of benchmark doses and confidence limits with clustered quantal data.
    Zhu Y; Wang T; Jelsovsky JZ
    Risk Anal; 2007 Apr; 27(2):447-65. PubMed ID: 17511711
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Use of the Fieller-Hinkley distribution of the ratio of random variables in testing for noninferiority.
    Koti KM
    J Biopharm Stat; 2007; 17(2):215-28. PubMed ID: 17365219
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Covariate-adjusted confidence interval for the intraclass correlation coefficient.
    Shoukri MM; Donner A; El-Dali A
    Contemp Clin Trials; 2013 Sep; 36(1):244-53. PubMed ID: 23871746
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Minor elevations in troponin T values enhance risk assessment in emergency department patients with suspected myocardial ischemia: analysis of novel troponin T cut-off values.
    Zarich SW; Bradley K; Mayall ID; Bernstein LH
    Clin Chim Acta; 2004 May; 343(1-2):223-9. PubMed ID: 15115700
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Proposal for a new protein therapeutic immunogenicity titer assay cutpoint.
    Wakshull E; Hendricks R; Amaya C; Coleman D
    Bioanalysis; 2011 Dec; 3(23):2627-36. PubMed ID: 22136051
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A sample size planning approach that considers both statistical significance and clinical significance.
    Jia B; Lynn HS
    Trials; 2015 May; 16():213. PubMed ID: 25962998
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Adaptive extensions of a two-stage group sequential procedure for testing primary and secondary endpoints (I): unknown correlation between the endpoints.
    Tamhane AC; Wu Y; Mehta CR
    Stat Med; 2012 Aug; 31(19):2027-40. PubMed ID: 22729929
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Accuracy in parameter estimation for ANCOVA and ANOVA contrasts: sample size planning via narrow confidence intervals.
    Lai K; Kelley K
    Br J Math Stat Psychol; 2012 May; 65(2):350-70. PubMed ID: 22004142
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Empirical Bayes models of Poisson clinical trials and sample size determination.
    Zaslavsky BG
    Pharm Stat; 2010; 9(2):133-41. PubMed ID: 19513984
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Small proportions: what to report for confidence intervals?
    Tobi H; van den Berg PB; de Jong-van den Berg LT
    Pharmacoepidemiol Drug Saf; 2005 Apr; 14(4):239-47. PubMed ID: 15719354
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Using the bootstrap to improve estimation and confidence intervals for regression coefficients selected using backwards variable elimination.
    Austin PC
    Stat Med; 2008 Jul; 27(17):3286-300. PubMed ID: 17940997
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sample size determination for controlling the upper confidence limit of incidence rate of a binomial endpoint.
    Shen LZ
    J Biopharm Stat; 1998 Jul; 8(3):489-96. PubMed ID: 9741861
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Application of analytical detection concepts to immunogenicity testing.
    Klakamp SL; Lu H; Tabrizi M; Funelas C; Roskos LK; Coleman D
    Anal Chem; 2007 Nov; 79(21):8176-84. PubMed ID: 17922557
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Confidence intervals based on some weighting functions for the difference of two binomial proportions.
    Maruo K; Kawai N
    Stat Med; 2014 Jun; 33(13):2288-96. PubMed ID: 24644149
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Adaptive extensions of a two-stage group sequential procedure for testing primary and secondary endpoints (II): sample size re-estimation.
    Tamhane AC; Wu Y; Mehta CR
    Stat Med; 2012 Aug; 31(19):2041-54. PubMed ID: 22733687
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Confidence intervals of effect size for paired studies.
    Wu J; Jiang G
    Biom J; 2007 Aug; 49(5):765-73. PubMed ID: 17634978
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Confidence intervals for the difference in paired Youden indices.
    Zhou H; Qin G
    Pharm Stat; 2013; 12(1):17-27. PubMed ID: 23090764
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Confidence intervals for a ratio of binomial proportions based on paired data.
    Bonett DG; Price RM
    Stat Med; 2006 Sep; 25(17):3039-47. PubMed ID: 16345058
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Bootstrap standard error and confidence intervals for the correlations corrected for indirect range restriction.
    Li JC; Chan W; Cui Y
    Br J Math Stat Psychol; 2011 Nov; 64(3):367-87. PubMed ID: 21973092
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.